A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Clinical trial NCT05534438 · RECRUITING

Trial details

NCT number: NCT05534438
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastatic Breast Carcinoma Breast Cancer Metastatic Breast Cancer Metastatic Breast Carcinoma ER+ Breast Cancer HER2+ Breast Cancer

Start date: 2022-09-06
Primary completion: 2026-09-06
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.